Fred Aslan's net worth is estimated to be at least $69,615.00 as of 10/09/2025. CoreStreet's estimation of Fred Aslan's net worth is based on their sale of stock and current holding of stock.

Fred Aslan is CEO at Artiva Biotherapeutics, Inc. Common Stock. They have executed at least 1 trades of stock as per SEC Form 4 filings. Their most recent trade was for 25,500 units of ARTV stock on 08/15/2025. Their biggest sale was on 08/15/2025 when they sold 25,500 units of Artiva Biotherapeutics, Inc. Common Stock stock for $69,615.00. They typically trade 1 times per year.

Fred Aslan's Insider Trading History